International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile
International Gyn Cancer Advocacy Network

@igcanetwork

Transcending barriers to create & empower patient advocates, unite advocacy groups, and improve the lives of those affected by gynecologic cancers worldwide.

ID: 1374930660

linkhttp://igcs.org calendar_today23-04-2013 16:33:38

2,2K Tweet

1,1K Followers

997 Following

International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

Too often, symptoms of uterine cancer—like irregular bleeding—are dismissed as “just part of aging.” Complete an anonymous survey for #UCAM 2025. Submit by April 11: bit.ly/UCAM-survey-az A project by IGCS, IGCAN & AstraZeneca. Digital media funded by AstraZeneca.

Too often, symptoms of uterine cancer—like irregular bleeding—are dismissed as “just part of aging.” Complete an anonymous survey for #UCAM 2025. 
Submit by April 11: bit.ly/UCAM-survey-az
A project by IGCS, IGCAN & AstraZeneca. Digital media funded by AstraZeneca.
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

We are thrilled to announce that we are now accepting your recommendations for the Dicey Scroggins Distinguished Advocate Award through May 1. igcs.org/distinguished-…

We are thrilled to announce that we are now accepting your recommendations for the Dicey Scroggins Distinguished Advocate Award through May 1.
igcs.org/distinguished-…
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

June is Uterine Cancer Awareness Month! Join IGCS-IGCAN for the 2025 global campaign by participating in the #UCAM #Jump4June Challenge! Help us elevate the message to new heights by accepting the challenge. igcs.org/jump4june

June is Uterine Cancer Awareness Month! Join IGCS-IGCAN for the 2025 global campaign by participating in the #UCAM #Jump4June Challenge!
Help us elevate the message to new heights by accepting the challenge. igcs.org/jump4june
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

Those affected by uterine cancer often face stigma & misinformation. Have you experienced this? Complete an anonymous survey for #UCAM 2025. Submit by April 11: bit.ly/UCAM-survey-az A project by IGCS, IGCAN & AstraZeneca. Digital media funded by AstraZeneca.

Those affected by uterine cancer often face stigma & misinformation. Have you experienced this? Complete an anonymous survey for #UCAM 2025. 
 
Submit by April 11: bit.ly/UCAM-survey-az
 
A project by IGCS, IGCAN & AstraZeneca. Digital media funded by AstraZeneca.
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

We are accepting your recommendations for the Dicey Scroggins Distinguished Advocate Award through May 1. Submit your recommendation today! Self-nominations accepted. igcs.org/distinguished-…

We are accepting your recommendations for the Dicey Scroggins Distinguished Advocate Award through May 1. 
Submit your recommendation today! Self-nominations accepted. 
igcs.org/distinguished-…
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

Make plans to participate in the 2025 #UterineCancer Awareness Month campaign – Accept the #UCAM #Jump4June Challenge! Plan a community activity this June or post your “jump” with facts and advocacy messages to about the most common #GynCancer this June. igcs.org/jump4june

Make plans to participate in the 2025 #UterineCancer Awareness Month campaign – Accept the #UCAM #Jump4June Challenge! Plan a community activity this June or post your “jump” with facts and advocacy messages to about the most common #GynCancer this June. igcs.org/jump4june
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

We want to feature YOU in this year’s IGCS-IGCAN #UCAM campaign! Submit a photo or video for the #Jump4June Challenge by May 10th and we will include your media as we raise awareness about #UterineCancer this June. Learn more: igcs.org/jump4june

We want to feature YOU in this year’s IGCS-IGCAN #UCAM campaign! Submit a photo or video for the #Jump4June Challenge by May 10th and we will include your media as we raise awareness about #UterineCancer this June. Learn more: igcs.org/jump4june
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

Just published in Journal of Cancer Policy! The Every Woman Study LMIC is the 1st to apply the WHO health systems framework to ovarian cancer. doi.org/10.1016/j.jcpo… Congrats to The World Ovarian Cancer Coalition and IGCS Members working together! World Ovarian Cancer Day & WOCCoalition

Just published in Journal of Cancer Policy! The Every Woman Study LMIC is the 1st to apply the WHO health systems framework to ovarian cancer.
doi.org/10.1016/j.jcpo…
Congrats to The World Ovarian Cancer Coalition and IGCS Members working together!

<a href="/OvCancerDay/">World Ovarian Cancer Day & WOCCoalition</a>
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

IGCS-IGCAN and our advocacy partners declared the month of JUNE as Uterine Cancer Awareness Month #UCAM in 2023. The awareness color for Uterine (also known as Womb & Endometrial) Cancer is PEACH. Visit igcs.org/ucam for more information about the most common #GYNCancer

IGCS-IGCAN and our advocacy partners declared the month of JUNE as Uterine Cancer Awareness Month #UCAM in 2023. The awareness color for Uterine (also known as Womb &amp; Endometrial) Cancer is PEACH. Visit igcs.org/ucam for more information about the most common #GYNCancer
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

The deadline to submit for the Dicey Scroggins Distinguished Advocate Award is quickly approaching! Submit your recommendation by Thursday, May 1 @ 11:59 PM EST! igcs.org/distinguished-…

The deadline to submit for the Dicey Scroggins Distinguished Advocate Award is quickly approaching! Submit your recommendation by Thursday, May 1 @ 11:59 PM EST! 
igcs.org/distinguished-…
International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

A Pap test does not detect ovarian cancer. It’s often diagnosed late—but early detection saves lives. Know the signs: bloating, pelvic pain, feeling full quickly, frequent urination. Listen to your body. World Ovarian Cancer Day & WOCCoalition #OvarianCancer #WorldOvarianCancerDay #WOCD2025

International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

Do you know what increases ovarian cancer risk? Age Family history BRCA1/2 or other mutations Jewish Eastern European ancestry HRT use Endometriosis Never pregnant Many have no risk—so learning the symptoms is key. World Ovarian Cancer Day & WOCCoalition #OvarianCancer #NoWomanLeftBehind #WOCD2025

International Gyn Cancer Advocacy Network (@igcanetwork) 's Twitter Profile Photo

This Uterine Cancer Awareness Month, pledge to support Awareness, Early Detection, Equitable Care, Survivorship Support & Inclusive Research. Your voice matters! 🤝 Pledge now 👉 igcs.org/ucam-pledge/ #UCAM #UterineCancerAwareness #Act4Women

This Uterine Cancer Awareness Month, pledge to support Awareness, Early Detection, Equitable Care, Survivorship Support &amp; Inclusive Research. Your voice matters! 🤝
Pledge now 👉 igcs.org/ucam-pledge/
#UCAM #UterineCancerAwareness #Act4Women
Colletta Orr (@collettaorr) 's Twitter Profile Photo

Ovarian cancer doesn’t just affect the ovaries, it can take a toll on your entire body before you even realize what’s happening. From hormonal changes to gut issues and fatigue, the signs are often silent. #OvarianCancerAwareness #KnowTheSigns #CollettaOrrAndAssociates

Ovarian cancer doesn’t just affect the ovaries, it can take a toll on your entire body before you even realize what’s happening. From hormonal changes to gut issues and fatigue, the signs are often silent. 

#OvarianCancerAwareness #KnowTheSigns #CollettaOrrAndAssociates
Ovarian Cancer Research Alliance (@ocrahope) 's Twitter Profile Photo

FDA (U.S. FDA) gives accelerated approval to Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets), making it the first FDA-approved treatment for recurrent low-grade serous ovarian cancer patients who have a KRAS mutation: bit.ly/43DI9pu. #GynCSM #LGSOC

FDA (<a href="/US_FDA/">U.S. FDA</a>) gives accelerated approval to Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets), making it the first FDA-approved treatment for recurrent low-grade serous ovarian cancer patients who have a KRAS mutation: bit.ly/43DI9pu. #GynCSM #LGSOC